Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
03/1999
03/09/1999US5880097 Tethered prodrugs
03/09/1999US5880094 Polypeptides that stimulate bone growth
03/09/1999US5879893 Hybridization method for detecting polynucleotides coding for signal transduction inhibitor protein in body fluids and tissue samples; treatment of alzheimer's disease and cancer
03/09/1999US5879713 Targeted delivery via biodegradable polymers
03/09/1999US5879711 Stable antiandrogenic gel composition
03/09/1999US5879698 Calcium dietary supplement
03/09/1999US5879688 Treatment of skin disorders, wrinkling, aging
03/09/1999US5879687 Enhancing or eliciting cellular and/or humoral immune response, for treating tumors
03/09/1999US5879672 Tie-2 ligand 1
03/09/1999CA1340430C Preparation of antihypercholesterolemic tetrazole compounds and intermediates thereof
03/08/1999CA2242476A1 Novel compositions containing cyclosporin
03/04/1999WO1999010525A1 A method of treating cancer
03/04/1999WO1999010524A1 A method of treating cancer
03/04/1999WO1999010516A2 Methods and compositions for therapies using genes encoding secreted proteins such as interferon-beta
03/04/1999WO1999010492A1 Adipocyte-specific protein homologs
03/04/1999WO1999010378A1 Pompilid wasp-derived neuropeptides
03/04/1999WO1999010338A2 Benzylidene- and cinnamylidene-anabaseines as neuronal nicotinic alpha-7 receptor agonists
03/04/1999WO1999010332A1 Prostaglandin endoperoxide h synthase biosynthesis inhibitors
03/04/1999WO1999010330A1 Heterocyclic ketones as npy y5 antagonists
03/04/1999WO1999010325A1 Benzylidene-1,3-dihydro-indol-2-one derivatives as receptor tyrosine kinase inhibitors, particularly of raf kinases
03/04/1999WO1999010324A1 AZETIDINONE DERIVATIVES AS β-LACTAMASE INHIBITORS
03/04/1999WO1999010014A2 Receptor-mediated gene delivery using bacteriophage vectors
03/04/1999WO1999009999A1 Specific saccharide compositions and methods for treating alzheimer's disease and other amyloidoses
03/04/1999WO1999009991A1 Novel amide derivatives
03/04/1999WO1999009985A1 Inhibitors of prenyl-protein transferase
03/04/1999WO1999009983A1 4-aryl-3-aminoquinoline-2-one derivatives as potassium channel modulators
03/04/1999WO1999009976A1 Anti-first-pass effect compounds
03/04/1999WO1999009973A1 Pharmacologic drug combination in vagal-induced asystole
03/04/1999WO1999009957A1 Pharmaceutical composition for combination of piperidinoalkanol-decongestant
03/04/1999WO1998055639A3 Recombinant adenoviral vectors comprising a splicing sequence
03/04/1999WO1998055600A3 New human ribonuclease
03/04/1999WO1998055074A3 Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome
03/04/1999WO1998054183A3 Ergoline derivatives and their use as somatostatin receptor antagonists
03/04/1999CA2302293A1 Receptor-mediated gene delivery using bacteriophage vectors
03/04/1999CA2301880A1 A method of treating cancer
03/04/1999CA2301857A1 A method of treating cancer
03/04/1999CA2301821A1 Heterocyclic ketones as npy y5 antagonists
03/04/1999CA2301770A1 Inhibitors of prenyl-protein transferase
03/04/1999CA2301660A1 Adipocyte-specific protein homologs
03/04/1999CA2301566A1 N-acylated lipophilic amino acid derivatives
03/04/1999CA2301549A1 4-aryl-3-aminoquinoline-2-one derivatives as potassium channel modulators
03/04/1999CA2301523A1 Azetidinone derivatives as .beta.-lactamase inhibitors
03/04/1999CA2294548A1 Pyridazinones as prostaglandin endoperoxide h synthase biosynthesis inhibitors
03/04/1999CA2245755A1 2-(arylphenyl)amino-imidazoline derivatives
03/04/1999CA2242260A1 Spo0j1
03/04/1999CA2242254A1 Novel tig
03/03/1999EP0899334A2 FtsZ polypeptides from Streptococcus pneumoniae
03/03/1999EP0899332A2 The G-protein coupled receptor HFIAO41
03/03/1999EP0899329A2 DextranaseB gene from Streptococcus pneumoniae
03/03/1999EP0899267A1 Disubstituted trans-3,4,4a,5,6,10b-hexahydro-2H-napht(1,2-b)-1,4-oxazines, process for their preparation and pharmaceutical compositions containing them
03/03/1999EP0899264A1 7-Phenyl-1,4-diazepane derivatives as neurokinine receptor antagonists
03/03/1999EP0899261A1 Optical active 1,4-dihydropyridine compounds as bradykinin antagonists
03/03/1999EP0898965A2 Use of tetrahydrofolates for modulating the homocysteine level
03/03/1999EP0898580A1 Methods and means for inhibition of cdk4 activity
03/03/1999EP0898569A1 Piperidines and pyrrolidines
03/03/1999EP0898567A1 Novel n-aminoalkyl-1-biphenylenyl-2-carboxamides; new dopamine receptor subtype specific ligands
03/03/1999EP0898562A1 Hydroxamic acid derivatives for use with the treatment of diseases related to connective tissue degradation
03/03/1999EP0898559A2 Cytoprotective compounds
03/03/1999EP0777666B1 Substituted piperidines useful for the treatment of allergic diseases
03/03/1999EP0745080B1 Novel mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace
03/03/1999EP0731791B1 benzenesulfonylimine derivatives as inhibitors of il-1 action
03/03/1999EP0724570B1 Amidino derivatives useful as nitric oxide synthase inhibitors
03/03/1999EP0626957B1 Styril derivatives and processes for their preparation
03/03/1999EP0595798B1 Bispecific heteroantibodies with dual effector functions
03/03/1999CN1209876A Isolated tyrosinase derived peptides and uses thereof
03/03/1999CN1209840A Noval CREBa phenogen
03/03/1999CN1209809A Noval chemical compound
03/03/1999CN1209805A Noval fused pyrrolecarboxamides and new class of GABA brain receptor ligands
03/03/1999CN1209754A Perfluoroalkyl-containing metal complexes, its preparing method and use in NMR diagnostics
03/03/1999CN1209751A Improved concentrated injection and infusion solutions for intravenous administration
03/03/1999CN1209750A Combined pharmaceutical preparation containing LHRH-analogous substances and anti-estrogens for treating gynaecological disorders
03/03/1999CN1209746A Method of inhibiting musculoaponeurotic fibromatoses (desmoid tumors)
03/03/1999CN1209744A Vitronectin receptor antagonists
03/03/1999CN1209319A Preparation method for medicinal composition containing aza-steroid compound for treating prostatic hyperplasia
03/03/1999CN1209316A Combined medicinal preparation of sodium/hydrogen exchange-pump inhibitor and medicine for treatment of angiocardiopathy
03/03/1999CN1042331C 4,6-dichloro-3-substituted-2-carboxy indole derivative
03/03/1999CN1042329C Substituted cyclohexane derivative for curing diseases
03/03/1999CN1042297C Method for preparing medicinal food
03/02/1999US5877316 Treatment of pain, inflammation, migraine and emesis.
03/02/1999US5877313 Benzo-fused azepinone and piperidinone compounds useful in the inhibition of ACE and NEP
03/02/1999US5877302 Compacted nucleic acids and their delivery to cells
03/02/1999US5877298 Acellular pertussis vaccines and methods of preparing thereof
03/02/1999US5877290 Humanized antibody fragment that binds a polypeptide sequence encoded by cdna of an anti-hypercalcemic hormone; treatment of electrolyte disorders, kidney failure, bone and heart disorders, osteoporosis, paget's disease
03/02/1999US5877213 Compositions and methods for therapy and prevention of cancer, AIDS, and anemia
03/02/1999US5877211 Prostaglandins
03/02/1999US5877208 Naringin and naringenin as 3-hydroxy-3-methylglutaryl CoA(HMG-CoA) reductase inhibitor
03/02/1999US5877207 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
03/02/1999US5877193 Use of N-(4-aryl-thiazol-2-yl)-sulfonamides
03/02/1999US5877190 Substituted biphenyl compounds
03/02/1999US5877187 Benzimidazole derivatives with antihistaminic activity
03/02/1999US5877179 Cystic fibrosis
03/02/1999US5877177 Carboxy piperidylacetamide tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
03/02/1999US5877158 Pro-prodrugs, their production and use
03/02/1999US5877155 Exposure of platelets to the molecule (anti-mimotope) in order to modulate adhesion, aggregation, or agglutination of the platelets.
03/02/1999US5876997 Phytase
03/02/1999US5876973 Method for making antibodies which specifically bind to glial growth factors
03/02/1999US5876969 Fusion polypeptide of therapeutic polypeptides attatched to c-and n-terminals of human serum albumin; for high plasma stability, minimization of dosage, side effect reduction
03/02/1999US5876965 Nucleic acid encoding ARF-19, a novel regulator of the mammalian cell cycle
03/02/1999US5876923 Screening suppressors which inhibit infected cell protein-4 polypetide by infecting cells with defective alpha-4 gene virus, incubating with compound allowing viral replication, comparing cell pathology
03/02/1999US5876749 Pharmaceutical composition
1 ... 1244 1245 1246 1247 1248 1249 1250 1251 1252 1253 1254 1255 1256 1257 1258 1259 1260 1261 1262 1263 1264 ... 1564